Nerve sheath tumours

por Robertson, James A., Tallantyre, Emma C.
Publicado 2018

How to run a multiple sclerosis relapse clinic

por Tallantyre, Emma C, Wardle, Mark, Robertson, Neil P
Publicado 2016

Tract-specific MRI measures explain learning and recall differences in multiple sclerosis

por Winter, Mia, Tallantyre, Emma C, Brice, Thomas A W, Robertson, Neil P, Jones, Derek K, Chamberland, Maxime
Publicado 2021

Neurological updates: neurological complications of CAR-T therapy

por Tallantyre, Emma C., Evans, Nia A., Parry-Jones, Jack, Morgan, Matt P. G., Jones, Ceri H., Ingram, Wendy
Publicado 2020

Tractography in the presence of multiple sclerosis lesions

por Lipp, Ilona, Parker, Greg D., Tallantyre, Emma C., Goodall, Alex, Grama, Steluta, Patitucci, Eleonora, Heveron, Phoebe, Tomassini, Valentina, Jones, Derek K.
Publicado 2020

Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study

por Lipp, Ilona, Foster, Catherine, Stickland, Rachael, Sgarlata, Eleonora, Tallantyre, Emma C, Davidson, Alison E, Robertson, Neil P, Jones, Derek K, Wise, Richard G, Tomassini, Valentina
Publicado 2020

Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis

por Lipp, Ilona, Jones, Derek K., Bells, Sonya, Sgarlata, Eleonora, Foster, Catherine, Stickland, Rachael, Davidson, Alison E., Tallantyre, Emma C., Robertson, Neil P., Wise, Richard G., Tomassini, Valentina
Publicado 2019

Decentralised clinical trials in multiple sclerosis research

por Garjani, Afagh, Liu, Brandon Jun-Yu, Allen, Christopher Martin, Gunzler, Douglas David, Gerry, Stephen William, Planchon, Sarah Marie, das Nair, Roshan, Chataway, Jeremy, Tallantyre, Emma C, Ontaneda, Daniel, Evangelou, Nikos
Publicado 2022

Detecting and predicting neutralization of alemtuzumab responses in MS

por Saxena, Gauri, Moore, James M., Jones, Meleri, Pryce, Gareth, Ali, Liaqat, Leisegang, Georgia R., Vijay, Vivek, Loveless, Samantha, Robertson, Neil P., Schmierer, Klaus, Giovannoni, Gavin, Gnananpavan, Sharmilee, Baker, David, Tallantyre, Emma C., Kang, Angray S.
Publicado 2020

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

por Garjani, Afagh, Middleton, Rodden M, Hunter, Rachael, Tuite-Dalton, Katherine A, Coles, Alasdair, Dobson, Ruth, Duddy, Martin, Hughes, Stella, Pearson, Owen R, Rog, David, Tallantyre, Emma C, das Nair, Roshan, Nicholas, Richard, Evangelou, Nikos
Publicado 2021

Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial

por Topcu, Gogem, Smith, Laura, Mhizha-Murira, Jacqueline R., Goulden, Nia, Hoare, Zoë, Drummond, Avril, Fitzsimmons, Deborah, Evangelou, Nikos, Schmierer, Klaus, Tallantyre, Emma C., Leighton, Paul, Allen-Philbey, Kimberley, Stennett, Andrea, Bradley, Paul, Bale, Clare, Turton, James, das Nair, Roshan
Publicado 2022

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis

por Tallantyre, Emma C, Scurr, Martin J, Vickaryous, Nicola, Richards, Aidan, Anderson, Valerie, Baker, David, Chance, Randy, Evangelou, Nikos, George, Katila, Giovannoni, Gavin, Harding, Katharine E, Hibbert, Aimee, Ingram, Gillian, Jolles, Stephen, Jones, Meleri, Kang, Angray S, Loveless, Samantha, Moat, Stuart J, Robertson, Neil P, Rios, Francesca, Schmierer, Klaus, Willis, Mark, Godkin, Andrew, Dobson, Ruth
Publicado 2022

COVID‐19 Vaccine Response in People with Multiple Sclerosis

por Tallantyre, Emma C., Vickaryous, Nicola, Anderson, Valerie, Asardag, Aliye Nazli, Baker, David, Bestwick, Jonathan, Bramhall, Kath, Chance, Randy, Evangelou, Nikos, George, Katila, Giovannoni, Gavin, Godkin, Andrew, Grant, Leanne, Harding, Katharine E., Hibbert, Aimee, Ingram, Gillian, Jones, Meleri, Kang, Angray S., Loveless, Samantha, Moat, Stuart J., Robertson, Neil P., Schmierer, Klaus, Scurr, Martin J., Shah, Sita Navin, Simmons, Jessica, Upcott, Matthew, Willis, Mark, Jolles, Stephen, Dobson, Ruth
Publicado 2021

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients

por Allen-Philbey, Kimberley, De Trane, Stefania, Mao, Zhifeng, Álvarez-González, Cesar, Mathews, Joela, MacDougall, Amy, Stennett, Andrea, Zhou, Xia, Yildiz, Ozlem, Adams, Ashok, Bianchi, Lucia, Blain, Camilla, Chapman, Christine, Chung, Karen, Constantinescu, Cris S, Dalton, Catherine, Farrell, Rachel A, Fisniku, Leonora, Ford, Helen, Gran, Bruno, Hobart, Jeremy, Khaleeli, Zhaleh, Mattoscio, Miriam, Pavitt, Sue, Pearson, Owen, Peruzzotti-Jametti, Luca, Scalfari, Antonio, Sharrack, Basil, Silber, Eli, Tallantyre, Emma C, Webb, Stewart, Turner, Benjamin P, Marta, Monica, Gnanapavan, Sharmilee, Juliusson, Gunnar, Giovannoni, Gavin, Baker, David, Schmierer, Klaus
Publicado 2021